Reisa A. Sperling
Physiology · 2003–2021
A researcher in the Science corpus: 29 papers; trusts 35 researchers and is trusted by 6 researchers here, as inferred from the citation graph.
Subfields
- Physiology — 442 citations into it
- Psychiatry and Mental health — 395 citations into it
- Cognitive Neuroscience — 200 citations into it; #5,248 of 10,852 by trust here, #558 by citations
- Neurology — 178 citations into it
- Molecular Biology — 133 citations into it
- Radiology, Nuclear Medicine and Imaging — 106 citations into it; #1,624 of 3,265 by trust here, #299 by citations
- Cellular and Molecular Neuroscience — 81 citations into it
- Materials Chemistry — 68 citations into it; #6,322 of 11,513 by trust here, #8,352 by citations
Whom Reisa A. Sperling trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Benoit Dubertret
- M. Meldal
- H. Braak
- E. Dujardin
- Clifford R. Jack Jr.
- Wolfgang J. Parak
- L. R. Squire
- T. Hyeon
- Christof Niemeyer
- Roberto Cabeza
Who trusts Reisa A. Sperling overall
- Moshe Bar
- C. Ong
- Clifford R. Jack Jr.
- Bruno Dubois
- L. Ng
- R. Swerdlow
- Harald Hampel
- Olaf Sporns
- A. Mohammad
- Katherine R. Gray
Papers from Reisa A. Sperling's perspective
Ordered by how strongly the researchers Reisa A. Sperling trusts endorse each paper. Same corpus, a different order for every researcher.
- Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory (Journal of Neuroscience)
- Neuropathological stageing of Alzheimer-related changes
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B (Annals of Neurology)
- Functional connectivity in the resting brain: A network analysis of the default mode hypothesis (Proceedings of the National Academy of Sciences of the United States of America)
- Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia (Proceedings of the National Academy of Sciences of the United States of America)
- The pathological process underlying Alzheimer’s disease in individuals under thirty (Acta Neuropathologica)
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives (Nature reviews. Drug discovery)
- Current concepts in mild cognitive impairment. (Archives of Neurology)
- Classification of primary progressive aphasia and its variants (Neurology)
- A default mode of brain function.
Their papers
- Introduction to Revised Criteria for the Diagnosis of Alzheimer’s Disease: National Institute on Aging and the Alzheimer Association Workgroups (2011) — 1,981 citations
- Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles (2010) — 1,555 citations
- The A4 Study: Stopping AD before Symptoms Begin? (2014) — 747 citations
- Brain charts for the human lifespan (2021) — 1,503 citations
- Four distinct trajectories of tau deposition identified in Alzheimer’s disease (2021) — 636 citations
- Changing the face of neuroimaging research: Comparing a new MRI de-facing technique with popular alternatives (2021)
- Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways (2019) — 783 citations
- Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report (2019) — 1,263 citations
- NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease (2018) — 3,155 citations
- Preclinical Alzheimer’s disease: Definition, natural history, and diagnostic criteria (2016) — 1,741 citations
- Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis (2016) — 1,062 citations
- Defeating Alzheimer's disease and other dementias: a priority for European science and society. (2016) — 1,473 citations
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers (2016) — 1,607 citations
- Different Partial Volume Correction Methods Lead to Different Conclusions: an 18F-FDG PET Study of Aging (2016) — 307 citations
- Alzheimer's disease (2015) — 1,237 citations
- Tau PET imaging in aging and early Alzheimer’s disease (2015) — 934 citations
- The evolution of preclinical Alzheimer’s disease: Implications for prevention trials (2014) — 679 citations
- The Preclinical Alzheimer Cognitive Composite (2014) — 799 citations
- A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease (2014) — 2,688 citations
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer’s Disease (2014) — 1,781 citations